cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA705977 | parathyroid gland, parathyroid tumor | .q-u | 1867 to 2264 | 409 to 13 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 397/397 (100 %) | 3 diff (99.3 %id) | |
AA299960 | uterus | .i | 204 to 528 | 1 to 325 | 325/325 (100 %) | 3 diff (99.1 %id) | |||
AA346520 | heart | .j | 5806 to 6146 | 1 to 338 | 338/339 (99 %) | 5 diff (98.6 %id) | |||
AA357394 | Kidney | .j | 6391 to 6716 | 1 to 327 | 327/327 (100 %) | 5 diff (98.5 %id) | |||
AA372001 | pituitary gland | .i | 244 to 565 | 1 to 322 | 322/322 (100 %) | 0 diff (100 %id) | |||
BP192720 | brain | .m | 1 to 579 | 1 to 582 | F136X G137W V138R L139S S140Q ... | tiling clone, | 582/582 (100 %) | 3 diff (99.5 %id) | |
BP194748 | brain | .i | 1 to 584 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
AF220560 | .a | 427 to 1890 | 1 to 1464 | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1464/1464 (100 %) | 2 diff (99.9 %id) | ||
AJ708012 | heart | .j | 4748 to 5080 | 16 to 348 | 333/348 (95 %) | 0 diff (100 %id) | |||
AK024121 | whole embryo, mainly body | .j | 3797 to 4559 | 833 to 1601 | available from FLJ, | 769/1601 (48 %) | 0 diff (100 %id) | ||
AK026647 | .j | 6920 to 7178 | 1 to 259 | available from FLJ, AAA | 259/259 (100 %) | 0 diff (100 %id) | |||
AK096327 | .j | 1 to 2007 | 2 to 2008 | available from FLJ, | 2008/2008 (100 %) | 0 diff (100 %id) | |||
AK097274 | Spleen | .c-u | 554 to 2523 | 1 to 1970 | tiling clone, available from FLJ, AAA | Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) | 1970/1970 (100 %) | 1 diff (100.0 %id) | |
AK098747 | brain | .e | 1 to 1698 | 2 to 1699 | exact | tiling clone, available from FLJ, | 1699/1699 (100 %) | 0 diff (100 %id) | |
AK296000 | subthalamic nucleus | .h | 112 to 1690 | 1 to 1579 | G125V | tiling clone, | 1579/1579 (100 %) | 2 diff (99.9 %id) | |
BP200581 | amygdala | .i | 87 to 668 | 1 to 581 | 581/581 (100 %) | 3 diff (99.5 %id) | |||
AW390432 | stomach | .i | 186 to 531 | 346 to 1 | 346/355 (97 %) | 13 diff (96.4 %id) | |||
AW800613 | uterus | .j | 3177 to 3497 | 733 to 424 | 310/740 (41 %) | 0 diff (100 %id) | |||
AW800629 | uterus | .j | 4537 to 4759 | 228 to 6 | 223/234 (95 %) | 0 diff (100 %id) | |||
AW849893 | colon | .j | 4703 to 4912 | 1 to 210 | 210/210 (100 %) | 1 diff (99.6 %id) | |||
AW856228 | colon | .i | 719 to 1249 | 537 to 7 | tiling clone, | 531/552 (96 %) | 2 diff (99.7 %id) | ||
AW890772 | nervous_tumor | .j | 4552 to 4867 | 22 to 338 | 317/348 (91 %) | 9 diff (97.5 %id) | |||
AW890774 | nervous_tumor | .j | 4556 to 4867 | 21 to 333 | 313/343 (91 %) | 6 diff (98.3 %id) | |||
AW905079 | nervous_normal | .h | 1686 to 2026 | 349 to 11 | tiling clone, | 339/372 (91 %) | 0 diff (100 %id) | ||
AW963392 | .i | 245 to 909 | 1 to 663 | tiling clone, | 663/664 (99 %) | 27 diff (96.0 %id) | |||
AW965828 | .j | 6392 to 6983 | 1 to 589 | 589/590 (99 %) | 17 diff (97.2 %id) | ||||
AW971541 | .q-u | 1731 to 2260 | 532 to 2 | Submitted on the opposite strand | 531/532 (99 %) | 0 diff (100 %id) | |||
BC004518 | Lung, small cell carcinoma | .a | 425 to 1890 | 1 to 1466 | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1466/1466 (100 %) | 1 diff (100.0 %id) | |
BC101749 | Liver, PCR rescued clones | .c-u | 451 to 2188 | 1 to 1738 | exact | 1738/1738 (100 %) | 0 diff (100 %id) | ||
BC101751 | Liver, PCR rescued clones | .c-u | 451 to 2194 | 1 to 1744 | exact | tiling clone, | 1744/1744 (100 %) | 0 diff (100 %id) | |
TI_927044854 | .c-u | 451 to 1195 | 46 to 793 | 748/895 (83 %) | 23 diff (97.5 %id) | ||||
TI_927044858 | .c-u | 451 to 1483 | 45 to 1074 | 1030/1201 (85 %) | 4 diff (99.7 %id) | ||||
TI_927046645 | .j | 1253 to 1684 | 10 to 440 | 431/1213 (35 %) | 5 diff (99.6 %id) | ||||
TI_927046646 | .j | 947 to 1684 | 1 to 738 | 738/1271 (58 %) | 8 diff (99.4 %id) | ||||
TI_927047174 | .j | 1248 to 1684 | 5 to 439 | 435/1118 (38 %) | 9 diff (99.2 %id) | ||||
TI_927047175 | .j | 950 to 1684 | 5 to 739 | 735/1090 (67 %) | 9 diff (99.2 %id) | ||||
TI_927044855 | .c-u | 451 to 1295 | 45 to 888 | 844/1059 (79 %) | 19 diff (98.3 %id) | ||||
TI_927044859 | .c-u | 451 to 1527 | 45 to 1121 | 1077/1233 (87 %) | 10 diff (99.2 %id) | ||||
TI_927046651 | .j | 1247 to 1678 | 1 to 429 | 429/1235 (34 %) | 6 diff (99.6 %id) | ||||
TI_927046652 | .j | 958 to 1678 | 12 to 731 | 720/1252 (57 %) | 2 diff (99.9 %id) | ||||
TI_927047179 | .j | 948 to 1678 | 1 to 731 | 731/1075 (68 %) | 6 diff (99.5 %id) | ||||
BE002908 | breast_normal | .j | 2405 to 2900 | 495 to 3 | Submitted on the opposite strand | 493/495 (99 %) | 0 diff (100 %id) | ||
BE005924 | breast_normal | .j | 1764 to 2451 | 686 to 2 | Submitted on the opposite strand | 685/686 (99 %) | 12 diff (98.3 %id) | ||
BE005988 | breast_normal | .j | 1782 to 2451 | 665 to 1 | Submitted on the opposite strand | 665/667 (99 %) | 11 diff (98.4 %id) | ||
BE091672 | breast | .i | 260 to 457 | 198 to 1 | Submitted on the opposite strand | 198/203 (97 %) | 2 diff (99.1 %id) | ||
BE185921 | head_neck | .j | 6371 to 6647 | 15 to 291 | 277/291 (95 %) | 0 diff (100 %id) | |||
BE828278 | lung_tumor | .j | 4290 to 4766 | 19 to 493 | 475/496 (95 %) | 9 diff (98.2 %id) | |||
BF082054 | breast_normal | .j | 3985 to 4445 | 471 to 6 | 466/518 (89 %) | 0 diff (100 %id) | |||
BF085972 | placenta_normal | .j | 6431 to 6659 | 1 to 230 | 230/246 (93 %) | 5 diff (98.0 %id) | |||
BF773527 | epid_tumor | .j | 4649 to 4819 | 197 to 22 | Submitted on the opposite strand | 176/197 (89 %) | 0 diff (100 %id) | ||
BF890696 | marrow | .q-u | 1461 to 1888 | 1 to 428 | 428/439 (97 %) | 7 diff (98.5 %id) | |||
BG897097 | cartilage | .j | 2075 to 2586 | 86 to 597 | 512/529 (96 %) | 0 diff (100 %id) | |||
BG897840 | cartilage | .j | 2504 to 2961 | 51 to 508 | 458/508 (90 %) | 0 diff (100 %id) | |||
BG990652 | head_neck | .j | 1561 to 2005 | 6 to 456 | 451/456 (98 %) | 0 diff (100 %id) | |||
BQ358877 | head_neck | .j | 1821 to 2156 | 343 to 6 | 338/343 (98 %) | 0 diff (100 %id) | |||
DA148573 | amygdala | .q-u | 1 to 567 | 2 to 568 | tiling clone, capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
DB301598 | amygdala | .q-u | 1723 to 2264 | 542 to 1 | tiling clone, | 542/542 (100 %) | 0 diff (100 %id) | ||
DC314391 | amygdala | .l | 1 to 551 | 1 to 551 | exact | tiling clone, | 551/551 (100 %) | 1 diff (99.9 %id) | |
DA175902 | amygdala | .o | 1 to 563 | 2 to 564 | exact | tiling clone, capped | 563/563 (100 %) | 1 diff (99.9 %id) | |
DA177295 | amygdala | .h | 1 to 417 | 2 to 418 | tiling clone, capped | 417/418 (99 %) | 2 diff (99.6 %id) | ||
DA188758 | amygdala | .e | 1 to 539 | 2 to 541 | capped | 540/540 (100 %) | 1 diff (99.9 %id) | ||
DC319904 | brain | .i | 1 to 557 | 1 to 557 | tiling clone, | 557/557 (100 %) | 1 diff (99.9 %id) | ||
DC320195 | brain | .i | 7 to 530 | 1 to 524 | 524/525 (99 %) | 1 diff (99.9 %id) | |||
DC338322 | subthalamic nucleus | .h | 112 to 660 | 1 to 549 | 549/549 (100 %) | 0 diff (100 %id) | |||
DA373939 | thalamus | .j | 74 to 635 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | ||
BX088745 | parathyroid gland, parathyroid tumor | .h | 1734 to 2438 | 1 to 706 | tiling clone, | 706/706 (100 %) | 1 diff (99.9 %id) | ||
BX103506 | breast | .j | 3195 to 3673 | 1 to 480 | 480/804 (59 %) | 5 diff (99.4 %id) | |||
BX106395 | whole brain | .a | 1421 to 1904 | 484 to 1 | Submitted on the opposite strand | 484/484 (100 %) | 0 diff (100 %id) | ||
BX108029 | heart | .j | 1440 to 2091 | 654 to 4 | Submitted on the opposite strand | 651/654 (99 %) | 0 diff (100 %id) | ||
Z38280 | brain, total brain | .g | 1218 to 1493 | 275 to 1 | 275/275 (100 %) | 1 diff (99.7 %id) | |||
Z41994 | brain, total brain | .g | 1 to 281 | 1 to 281 | tiling clone, | 281/281 (100 %) | 0 diff (100 %id) | ||
BX404320 | neuroblastoma | .j | 852 to 1197 | 346 to 1 | 346/346 (100 %) | 1 diff (99.8 %id) | |||
CN278976 | embryonic stem cells, cell lines H1, H7, andH9 | .j | 5006 to 5275 | 1 to 270 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 270/270 (100 %) | 0 diff (100 %id) | |
CN278977 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .j | 5126 to 5851 | 1 to 727 | 727/727 (100 %) | 4 diff (99.5 %id) | |||
CN280807 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c-u | 162 to 495 | 1 to 334 | tiling clone, | 334/334 (100 %) | 7 diff (98.0 %id) | ||
CN288775 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .j | 6276 to 6609 | 1 to 334 | 334/334 (100 %) | 3 diff (99.2 %id) | |||
CN364006 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 37 to 600 | 1 to 564 | tiling clone, | 564/564 (100 %) | 0 diff (100 %id) | ||
CR595216 | Neuroblastoma Cot 25-normalized | .b | 1 to 1695 | 1 to 1695 | tiling clone, | 1695/1695 (100 %) | 0 diff (100 %id) | ||
AL523922 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .b | 871 to 1695 | 824 to 1 | fully sequenced, | 824/824 (100 %) | 30 diff (96.4 %id) | ||
AL523923 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .b | 1 to 901 | 1 to 896 | fully sequenced, | 896/896 (100 %) | 8 diff (99.2 %id) | ||
BX374951 | Neuroblastoma Cot 25-normalized | .c-u | 78 to 937 | 1 to 859 | 859/859 (100 %) | 3 diff (99.7 %id) | |||
BX335323 | Placenta Cot 25-normalized | .c-u | 47 to 1014 | 1 to 964 | 964/964 (100 %) | 5 diff (99.5 %id) | |||
BX338638 | Placenta Cot 25-normalized | .c-u | 57 to 1030 | 1 to 967 | tiling clone, | 967/967 (100 %) | 10 diff (99.0 %id) | ||
BX370145 | Placenta Cot 25-normalized | .j | 219 to 801 | 1 to 588 | 588/1001 (58 %) | 23 diff (97.8 %id) | |||
BX382445 | Placenta Cot 25-normalized | .c-u | 18 to 1034 | 1 to 1003 | tiling clone, | 1003/1062 (94 %) | 17 diff (98.4 %id) | ||
CA389452 | eye, RPE/choroid | .a | 104 to 596 | 1 to 493 | 493/493 (100 %) | 0 diff (100 %id) | |||
CA396105 | eye, RPE/choroid | .j | 1356 to 1848 | 1 to 493 | 493/493 (100 %) | 0 diff (100 %id) | |||
CU447631 | epidermis | .j | 1933 to 2708 | 7 to 783 | 777/783 (99 %) | 0 diff (100 %id) | |||
CU448832 | epidermis | .j | 1773 to 2200 | 442 to 16 | Submitted on the opposite strand | 427/444 (96 %) | 0 diff (100 %id) | ||
CU455281 | epidermis | .j | 2009 to 2794 | 797 to 13 | Submitted on the opposite strand | 785/797 (98 %) | 0 diff (100 %id) | ||
CV026444 | mixed | .a | 435 to 1044 | 1 to 610 | 610/610 (100 %) | 0 diff (100 %id) | |||
CV342614 | kidney_tumor | .q-u | 1766 to 1942 | 1 to 179 | 179/186 (96 %) | 10 diff (94.7 %id) | |||
AL047552 | uterus | .j | 3082 to 3335 | 20 to 273 | 254/273 (93 %) | 0 diff (100 %id) | |||
AL047553 | uterus | .j | 3566 to 3988 | 466 to 45 | AAA | 422/455 (92 %) | 0 diff (100 %id) | ||
DT220986 | brain | .a | 358 to 1017 | 1 to 660 | 660/660 (100 %) | 1 diff (99.9 %id) | |||
DW432681 | Liver | .j | 2892 to 3140 | 17 to 265 | 249/265 (93 %) | 0 diff (100 %id) | |||
DW432682 | Liver | .j | 2892 to 3140 | 17 to 265 | 249/265 (93 %) | 0 diff (100 %id) | |||
EH339296 | .j | 6547 to 6640 | 1 to 93 | 93/93 (100 %) | 2 diff (97.9 %id) | ||||
EH345731 | .j | 3259 to 3334 | 1 to 76 | 76/76 (100 %) | 0 diff (100 %id) | ||||
Z21602 | .j | 5013 to 5221 | 20 to 227 | 208/227 (91 %) | 0 diff (100 %id) | ||||
FN049083 | breast carcinoma | .j | 6994 to 7101 | 1 to 108 | 108/108 (100 %) | 0 diff (100 %id) | |||
FN084375 | breast carcinoma | .j | 5156 to 5223 | 68 to 1 | Submitted on the opposite strand | 68/68 (100 %) | 0 diff (100 %id) | ||
FN120375 | breast carcinoma | .j | 5200 to 5268 | 1 to 69 | 69/76 (90 %) | 1 diff (98.7 %id) | |||
FN160757 | breast carcinoma | .j | 7092 to 7181 | 1 to 87 | 87/90 (96 %) | 5 diff (94.5 %id) | |||
FN163923 | breast carcinoma | .j | 5481 to 5603 | 1 to 116 | 116/116 (100 %) | 5 diff (95.7 %id) | |||
G36733 | .j | 4933 to 5273 | 342 to 1 | Submitted on the opposite strand | 342/342 (100 %) | 3 diff (99.2 %id) | |||
DB532648 | hippocampus | .q-u | 1842 to 2264 | 1 to 423 | Submitted on the opposite strand | 423/423 (100 %) | 1 diff (99.8 %id) | ||
DB470310 | hippocampus | .i | 112 to 548 | 1 to 436 | 436/436 (100 %) | 1 diff (99.8 %id) | |||
DB471091 | hippocampus | .p | 1 to 473 | 1 to 472 | G27R A117D | tiling clone, | 472/475 (99 %) | 5 diff (99.0 %id) | |
DB475713 | hippocampus | .p | 1 to 489 | 1 to 489 | G27R | tiling clone, | 489/489 (100 %) | 2 diff (99.6 %id) | |
DB478429 | hippocampus | .a | 1 to 447 | 1 to 447 | tiling clone, | 447/460 (97 %) | 4 diff (99.2 %id) | ||
DB482383 | hippocampus | .e | 3 to 492 | 1 to 492 | 492/497 (98 %) | 16 diff (96.8 %id) | |||
BP264924 | muscle | .a | 952 to 1662 | 1 to 717 | 717/1011 (70 %) | 11 diff (99.0 %id) | |||
AI753700 | bone marrow stroma | .j | 6775 to 7178 | 431 to 28 | AAA | 404/404 (100 %) | 0 diff (100 %id) | ||
AU146463 | whole embryo, mainly body | .j | 4081 to 4554 | 487 to 6 | 482/494 (97 %) | 0 diff (100 %id) | |||
DA595766 | lung | .q-u | 293 to 858 | 2 to 566 | exact | tiling clone, capped | 565/565 (100 %) | 1 diff (99.9 %id) | |
BP398326 | pancreatic islet | .q-u | 1909 to 2260 | 1 to 347 | Submitted on the opposite strand | 347/347 (100 %) | 10 diff (97.2 %id) | ||
H23265 | whole brain | .g | 1145 to 1502 | 362 to 1 | tiling clone, | 362/403 (89 %) | 6 diff (98.6 %id) | ||
H23376 | whole brain | .g | 2 to 352 | 1 to 351 | tiling clone, | 351/351 (100 %) | 0 diff (100 %id) | ||
R68455 | placenta | .j | 1993 to 2404 | 421 to 1 | Submitted on the opposite strand | 421/439 (95 %) | 22 diff (95.0 %id) | ||
R68456 | placenta | .j | 1198 to 1483 | 1 to 285 | Submitted on the opposite strand | 285/285 (100 %) | 8 diff (97.2 %id) | ||
H62860 | liver and spleen | .j | 2675 to 3035 | 1 to 368 | Submitted on the opposite strand | 368/372 (98 %) | 8 diff (97.9 %id) | ||
H62980 | liver and spleen | .j | 3584 to 3877 | 293 to 1 | Submitted on the opposite strand | 293/293 (100 %) | 12 diff (96.0 %id) | ||
H67608 | liver and spleen | .j | 3476 to 3877 | 412 to 1 | Submitted on the opposite strand | 412/456 (90 %) | 24 diff (94.8 %id) | ||
H82086 | melanocyte | .j | 1247 to 1547 | 1 to 308 | Submitted on the opposite strand | 308/308 (100 %) | 15 diff (95.2 %id) | ||
H82193 | melanocyte | .j | 1683 to 2009 | 330 to 1 | Submitted on the opposite strand | 330/330 (100 %) | 3 diff (99.1 %id) | ||
H96888 | melanocyte | .j | 1248 to 1633 | 1 to 392 | Submitted on the opposite strand | 392/392 (100 %) | 13 diff (96.7 %id) | ||
N20871 | melanocyte | .j | 1206 to 1680 | 17 to 504 | Submitted on the opposite strand | 488/537 (90 %) | 19 diff (96.5 %id) | ||
N27713 | melanocyte | .j | 1530 to 2022 | 504 to 8 | Submitted on the opposite strand | 497/505 (98 %) | 0 diff (100 %id) | ||
N26054 | melanocyte | .j | 1214 to 1745 | 1 to 537 | Submitted on the opposite strand | 537/561 (95 %) | 23 diff (96.0 %id) | ||
N40418 | melanocyte | .j | 1577 to 2008 | 434 to 1 | Submitted on the opposite strand | 434/434 (100 %) | 2 diff (99.6 %id) | ||
N25200 | melanocyte | .j | 1215 to 1667 | 1 to 438 | Submitted on the opposite strand | 438/442 (99 %) | 34 diff (92.4 %id) | ||
N36071 | melanocyte | .j | 1473 to 2002 | 539 to 1 | Submitted on the opposite strand | 539/541 (99 %) | 12 diff (97.8 %id) | ||
N33239 | melanocyte | .j | 1214 to 1527 | 1 to 312 | Submitted on the opposite strand | 312/312 (100 %) | 7 diff (97.8 %id) | ||
N41954 | melanocyte | .j | 1568 to 2002 | 440 to 1 | Submitted on the opposite strand | 440/527 (83 %) | 12 diff (97.8 %id) | ||
N33421 | melanocyte | .j | 1214 to 1500 | 1 to 284 | Submitted on the opposite strand | 284/284 (100 %) | 8 diff (97.2 %id) | ||
N42396 | melanocyte | .j | 1532 to 1966 | 435 to 1 | Submitted on the opposite strand | 435/435 (100 %) | 1 diff (99.8 %id) | ||
N34341 | melanocyte | .j | 1189 to 1642 | 1 to 455 | Submitted on the opposite strand | 455/455 (100 %) | 10 diff (97.9 %id) | ||
N42576 | melanocyte | .j | 1578 to 2013 | 439 to 1 | Submitted on the opposite strand | 439/441 (99 %) | 3 diff (99.4 %id) | ||
AA011093 | heart | .j | 1792 to 2080 | 290 to 1 | Submitted on the opposite strand | 290/294 (98 %) | 9 diff (97.0 %id) | ||
AA011094 | heart | .j | 1190 to 1531 | 1 to 346 | Submitted on the opposite strand | 346/418 (82 %) | 10 diff (97.7 %id) | ||
AA045083 | uterus | .j | 4933 to 5273 | 342 to 1 | 342/342 (100 %) | 3 diff (99.2 %id) | |||
AA045399 | uterus | .j | 4150 to 4615 | 1 to 468 | 468/473 (98 %) | 9 diff (98.1 %id) | |||
AA708933 | uterus | .j | 4253 to 4559 | 307 to 1 | 307/307 (100 %) | 0 diff (100 %id) | |||
AA256430 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 941 to 1174 | 235 to 1 | fully sequenced, | 235/235 (100 %) | 4 diff (98.3 %id) | ||
AA256841 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 660 to 971 | 1 to 308 | fully sequenced, | 308/308 (100 %) | 3 diff (99.1 %id) | ||
AA250917 | germinal center B cell | .q-u | 1324 to 1491 | 1 to 168 | tiling clone, | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 168/168 (100 %) | 0 diff (100 %id) | |
AA253461 | germinal center B cell | .q-u | 1906 to 2260 | 365 to 11 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 355/355 (100 %) | 0 diff (100 %id) | |
AA281105 | germinal center B cell | .j | 1190 to 1533 | 1 to 344 | Submitted on the opposite strand | 344/344 (100 %) | 4 diff (98.9 %id) | ||
AA293257 | ovarian tumor, ovary | .j | 332 to 714 | 1 to 373 | 373/373 (100 %) | 11 diff (97.1 %id) | |||
AA410310 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 6963 to 7181 | 222 to 4 | 219/222 (98 %) | 0 diff (100 %id) | |||
AA410535 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 2045 to 2436 | 1 to 391 | 391/391 (100 %) | 4 diff (99.0 %id) | |||
AA430410 | ovarian tumor, ovary | .j | 1190 to 1681 | 1 to 491 | Submitted on the opposite strand | 491/491 (100 %) | 9 diff (98.2 %id) | ||
AA430639 | ovarian tumor, ovary | .j | 1561 to 2002 | 442 to 1 | Submitted on the opposite strand | 442/443 (99 %) | 2 diff (99.6 %id) | ||
AA430466 | ovarian tumor, ovary | .j | 1189 to 1674 | 1 to 482 | Submitted on the opposite strand | 482/482 (100 %) | 8 diff (98.4 %id) | ||
AA490463 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 6618 to 6925 | 1 to 310 | Submitted on the opposite strand | 310/310 (100 %) | 3 diff (99.1 %id) | ||
AA669119 | germinal center B cell | .j | 1263 to 1720 | 1 to 455 | Submitted on the opposite strand | 455/455 (100 %) | 4 diff (99.2 %id) | ||
AA515633 | liposarcoma | .j | 4981 to 5283 | 303 to 1 | 303/303 (100 %) | 2 diff (99.4 %id) | |||
AA527740 | Prostate | .j | 6773 to 7160 | 1 to 388 | 388/389 (99 %) | 7 diff (98.3 %id) | |||
AA553676 | colon | .j | 1190 to 1568 | 1 to 379 | Submitted on the opposite strand | 379/379 (100 %) | 0 diff (100 %id) | ||
AA779493 | .j | 5147 to 5282 | 137 to 1 | 137/137 (100 %) | 1 diff (99.3 %id) | ||||
AA576821 | colon, colon tumor RER+ | .j | 683 to 1171 | 486 to 1 | 486/486 (100 %) | 3 diff (99.4 %id) | |||
AI732650 | colon, colon tumor RER+ | .j | 651 to 1173 | 523 to 1 | 523/523 (100 %) | 3 diff (99.5 %id) | |||
AI791946 | colon, colon tumor RER+ | .j | 327 to 801 | 1 to 475 | 475/475 (100 %) | 0 diff (100 %id) | |||
AA582985 | larynx | .j | 1705 to 1995 | 291 to 1 | 291/291 (100 %) | 0 diff (100 %id) | |||
AA789157 | .a | 1395 to 1892 | 497 to 1 | 497/497 (100 %) | 2 diff (99.6 %id) | ||||
AA631997 | breast | .j | 4738 to 5272 | 535 to 1 | 535/535 (100 %) | 0 diff (100 %id) | |||
AA632162 | breast | .j | 4878 to 5272 | 395 to 1 | 395/395 (100 %) | 0 diff (100 %id) | |||
AA877578 | colon, colon tumor RER+ | .j | 1190 to 1708 | 1 to 519 | Submitted on the opposite strand | 519/519 (100 %) | 8 diff (98.5 %id) | ||
AA628084 | normal prostate, Prostate | .j | 7004 to 7178 | 175 to 1 | fully sequenced, | 175/175 (100 %) | 0 diff (100 %id) | ||
AA651751 | normal prostate, Prostate | .j | 6827 to 7178 | 1 to 352 | fully sequenced, AAA | 352/352 (100 %) | 0 diff (100 %id) | ||
AA737668 | germinal center B cell | .j | 785 to 1168 | 383 to 1 | 383/383 (100 %) | 3 diff (99.3 %id) | |||
AA743530 | germinal center B cell | .j | 1259 to 1641 | 1 to 382 | Submitted on the opposite strand | 382/382 (100 %) | 5 diff (98.7 %id) | ||
AA768845 | germinal center B cell | .j | 1257 to 1931 | 1 to 679 | Submitted on the opposite strand | 679/889 (76 %) | 34 diff (96.2 %id) | ||
AA746275 | germinal center B cell | .j | 1488 to 1691 | 201 to 1 | Submitted on the opposite strand | 201/201 (100 %) | 3 diff (98.6 %id) | ||
AA748392 | germinal center B cell | .j | 1256 to 1600 | 1 to 345 | Submitted on the opposite strand | 345/345 (100 %) | 3 diff (99.2 %id) | ||
AA769035 | germinal center B cell | .n | 42 to 488 | 10 to 455 | tiling clone, | Submitted on the opposite strand | 446/447 (99 %) | 4 diff (99.2 %id) | |
AA746140 | Kidney | .j | 5008 to 5275 | 268 to 1 | 268/268 (100 %) | 0 diff (100 %id) | |||
AA830441 | germinal center B cell | .j | 1277 to 1601 | 1 to 323 | Submitted on the opposite strand | 323/323 (100 %) | 9 diff (97.3 %id) | ||
AA824544 | germinal center B cell | .j | 1242 to 1477 | 1 to 235 | 235/235 (100 %) | 8 diff (96.6 %id) | |||
AA854894 | parathyroid gland, parathyroid tumor | .j | 1266 to 1627 | 1 to 359 | Submitted on the opposite strand | 359/359 (100 %) | 5 diff (98.7 %id) | ||
AA860553 | parathyroid gland, parathyroid tumor | .j | 1217 to 1608 | 1 to 389 | Submitted on the opposite strand | 389/389 (100 %) | 9 diff (97.7 %id) | ||
AA911831 | adenocarcinoma, colon | .j | 1190 to 1569 | 1 to 376 | Submitted on the opposite strand | 376/376 (100 %) | 13 diff (96.6 %id) | ||
AA883429 | pooled | .j | 1216 to 1686 | 1 to 468 | Submitted on the opposite strand | 468/468 (100 %) | 9 diff (98.1 %id) | ||
AA897724 | pooled | .j | 1215 to 1373 | 1 to 159 | Submitted on the opposite strand | 159/159 (100 %) | 2 diff (98.8 %id) | ||
AA927306 | pooled | .j | 4106 to 4559 | 454 to 1 | 454/454 (100 %) | 0 diff (100 %id) | |||
AA928730 | adenocarcinoma, colon | .j | 743 to 1193 | 447 to 3 | 445/447 (99 %) | 0 diff (100 %id) | |||
AI733225 | adenocarcinoma, colon | .j | 763 to 1173 | 412 to 1 | 412/412 (100 %) | 3 diff (99.3 %id) | |||
AI793161 | adenocarcinoma, colon | .j | 710 to 1168 | 1 to 460 | 460/462 (99 %) | 2 diff (99.6 %id) | |||
AA975503 | pooled | .j | 1190 to 1680 | 1 to 487 | Submitted on the opposite strand | 487/496 (98 %) | 10 diff (98.0 %id) | ||
AA988888 | carcinoid, lung | .j | 4197 to 4558 | 362 to 1 | 362/362 (100 %) | 0 diff (100 %id) | |||
AA993935 | pooled | .j | 1191 to 1393 | 1 to 198 | Submitted on the opposite strand | 198/198 (100 %) | 8 diff (96.0 %id) | ||
AI023147 | senescent fibroblast | .j | 3097 to 3226 | 141 to 12 | AAA | Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) | 130/130 (100 %) | 0 diff (100 %id) | |
AI140528 | liver and spleen | .q-u | 649 to 1039 | 391 to 1 | tiling clone, | 391/391 (100 %) | 1 diff (99.8 %id) | ||
AI033562 | liver and spleen | .a | 1662 to 1891 | 230 to 1 | 230/230 (100 %) | 2 diff (99.2 %id) | |||
AI144396 | heart | .j | 1215 to 1677 | 1 to 463 | Submitted on the opposite strand | 463/463 (100 %) | 0 diff (100 %id) | ||
AI160709 | placenta | .j | 4067 to 4559 | 493 to 1 | 493/493 (100 %) | 0 diff (100 %id) | |||
AI143663 | anaplastic oligodendroglioma, brain | .j | 1217 to 1375 | 1 to 159 | Submitted on the opposite strand | 159/159 (100 %) | 2 diff (98.8 %id) | ||
AI198195 | anaplastic oligodendroglioma, brain | .j | 1190 to 1634 | 1 to 443 | Submitted on the opposite strand | 443/443 (100 %) | 6 diff (98.7 %id) | ||
AI214598 | carcinoid, lung | .j | 6648 to 7070 | 1 to 423 | Submitted on the opposite strand | 423/423 (100 %) | 2 diff (99.6 %id) | ||
AI302060 | carcinoid, lung | .q-u | 1868 to 2264 | 397 to 1 | 397/397 (100 %) | 1 diff (99.8 %id) | |||
AI309919 | adenocarcinoma, colon | .j | 1215 to 1588 | 1 to 374 | Submitted on the opposite strand | 374/374 (100 %) | 1 diff (99.8 %id) | ||
AI202298 | Prostate | .j | 1215 to 1489 | 1 to 275 | Submitted on the opposite strand | 275/275 (100 %) | 0 diff (100 %id) | ||
AI201744 | Prostate | .j | 1215 to 1661 | 1 to 447 | Submitted on the opposite strand | 447/447 (100 %) | 0 diff (100 %id) | ||
AI338680 | lung | .j | 1215 to 1662 | 1 to 448 | Submitted on the opposite strand | 448/448 (100 %) | 2 diff (99.6 %id) | ||
AI287698 | ovary, tumor, 5 pooled (see description) | .a | 1567 to 1892 | 328 to 1 | 328/329 (99 %) | 3 diff (99.1 %id) | |||
AI283310 | ovary, tumor, 5 pooled (see description) | .j | 806 to 1181 | 376 to 1 | 376/376 (100 %) | 0 diff (100 %id) | |||
AI363311 | brain, glioblastoma (pooled) | .a | 1227 to 1890 | 664 to 1 | 664/664 (100 %) | 9 diff (98.7 %id) | |||
AI377935 | pooled | .j | 1215 to 1665 | 1 to 451 | Submitted on the opposite strand | 451/458 (98 %) | 3 diff (99.4 %id) | ||
AI424236 | Prostate | .j | 872 to 1173 | 302 to 1 | 302/302 (100 %) | 0 diff (100 %id) | |||
AI417662 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 6810 to 7181 | 374 to 4 | 371/374 (99 %) | 0 diff (100 %id) | |||
AI458417 | pooled | .j | 1215 to 1939 | 1 to 723 | Submitted on the opposite strand | 723/1133 (63 %) | 15 diff (98.7 %id) | ||
AI570451 | anaplastic oligodendroglioma, brain | .j | 4826 to 5275 | 450 to 1 | 450/450 (100 %) | 0 diff (100 %id) | |||
AI570714 | anaplastic oligodendroglioma, brain | .j | 1215 to 1672 | 1 to 458 | Submitted on the opposite strand | 458/458 (100 %) | 0 diff (100 %id) | ||
AI537648 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .j | 6872 to 7181 | 316 to 7 | 310/316 (98 %) | 0 diff (100 %id) | |||
AI568084 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .q-u | 2043 to 2263 | 221 to 1 | 221/221 (100 %) | 0 diff (100 %id) | |||
AI654652 | ovary, tumor, 5 pooled (see description) | .q-u | 1831 to 2263 | 433 to 1 | 433/433 (100 %) | 0 diff (100 %id) | |||
AI915016 | ovary, tumor, 5 pooled (see description) | .j | 6974 to 7178 | 223 to 19 | AAA | 205/205 (100 %) | 1 diff (99.6 %id) | ||
AI569111 | adenocarcinoma, Pancreas | .q-u | 1860 to 2263 | 405 to 2 | 404/405 (99 %) | 0 diff (100 %id) | |||
AI690296 | carcinoid, lung | .j | 4054 to 4558 | 505 to 1 | 505/505 (100 %) | 2 diff (99.7 %id) | |||
AI913092 | Kidney | .j | 1215 to 1664 | 1 to 448 | Submitted on the opposite strand | 448/448 (100 %) | 3 diff (99.4 %id) | ||
AI916551 | Kidney | .j | 4996 to 5274 | 281 to 3 | 279/281 (99 %) | 0 diff (100 %id) | |||
AI914047 | carcinoid, lung | .n | 67 to 459 | 1 to 393 | Submitted on the opposite strand | 393/393 (100 %) | 1 diff (99.8 %id) | ||
AI673636 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .j | 6472 to 6843 | 386 to 14 | 373/386 (96 %) | 0 diff (100 %id) | |||
AI766311 | Kidney | .j | 4043 to 4559 | 517 to 1 | 517/517 (100 %) | 2 diff (99.7 %id) | |||
AI825997 | normal prostate, Prostate | .j | 1242 to 1456 | 1 to 215 | Submitted on the opposite strand | 215/215 (100 %) | 0 diff (100 %id) | ||
AI858639 | anaplastic oligodendroglioma, brain | .j | 759 to 1173 | 415 to 1 | 415/415 (100 %) | 1 diff (99.8 %id) | |||
AI926033 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .j | 3635 to 4017 | 383 to 1 | 383/383 (100 %) | 1 diff (99.8 %id) | |||
AI948702 | Kidney | .a | 1425 to 1890 | 466 to 1 | 466/466 (100 %) | 9 diff (98.1 %id) | |||
AI953570 | Kidney | .j | 867 to 1173 | 307 to 1 | 307/307 (100 %) | 1 diff (99.7 %id) | |||
AI971538 | pooled germ cell tumors | .j | 1771 to 2080 | 340 to 31 | AAA | Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) | 310/310 (100 %) | 13 diff (95.9 %id) | |
AI984768 | Kidney | .j | 6756 to 7177 | 423 to 1 | 423/423 (100 %) | 7 diff (98.4 %id) | |||
AW026614 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .j | 804 to 1181 | 378 to 1 | 378/378 (100 %) | 6 diff (98.5 %id) | |||
AW149485 | brain, medulloblastoma | .a | 334 to 837 | 1 to 505 | Submitted on the opposite strand | 505/505 (100 %) | 2 diff (99.7 %id) | ||
AW016264 | .j | 1191 to 1582 | 1 to 392 | Submitted on the opposite strand | 392/392 (100 %) | 3 diff (99.3 %id) | |||
AW136805 | .a | 1570 to 1890 | 338 to 18 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 321/321 (100 %) | 0 diff (100 %id) | ||
AW203992 | .j | 4710 to 5233 | 12 to 535 | Submitted on the opposite strand | 524/535 (97 %) | 0 diff (100 %id) | |||
AW451088 | .j | 693 to 1196 | 505 to 1 | 505/505 (100 %) | 4 diff (99.3 %id) | ||||
AW451113 | .j | 709 to 1196 | 488 to 1 | 488/488 (100 %) | 3 diff (99.4 %id) | ||||
AW451977 | .j | 772 to 1196 | 425 to 1 | 425/425 (100 %) | 0 diff (100 %id) | ||||
AW517032 | cervix | .a | 1519 to 1890 | 371 to 1 | 371/372 (99 %) | 1 diff (99.8 %id) | |||
AW514123 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .q-u | 757 to 1039 | 283 to 1 | tiling clone, | 283/283 (100 %) | 2 diff (99.3 %id) | ||
AW471156 | colon, moderately-differentiated adenocarcinoma | .j | 912 to 1197 | 287 to 2 | 286/287 (99 %) | 0 diff (100 %id) | |||
AW302471 | brain, three pooled meningiomas | .j | 6467 to 6823 | 357 to 1 | 357/357 (100 %) | 0 diff (100 %id) | |||
AW512260 | lymph node, lymphoma, follicular mixed small and largecell | .q-u | 1840 to 2260 | 461 to 41 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 421/421 (100 %) | 3 diff (99.3 %id) | |
AW518492 | lymph node, lymphoma, follicular mixed small and largecell | .r-u | 1 to 374 | 376 to 1 | exact | tiling clone, | 376/376 (100 %) | 4 diff (99.0 %id) | |
AW665107 | pooled | .j | 1225 to 1395 | 1 to 171 | Submitted on the opposite strand | 171/171 (100 %) | 0 diff (100 %id) | ||
BU430408 | lymph | .j | 3529 to 4030 | 509 to 8 | Submitted on the opposite strand | 502/509 (98 %) | 0 diff (100 %id) | ||
AW500161 | lymph | .j | 3465 to 4033 | 592 to 24 | Submitted on the opposite strand | 569/592 (96 %) | 0 diff (100 %id) | ||
BF514942 | .j | 789 to 1196 | 408 to 1 | 408/422 (96 %) | 0 diff (100 %id) | ||||
BF196505 | Kidney | .a | 1320 to 1890 | 571 to 1 | 571/571 (100 %) | 0 diff (100 %id) | |||
BE222277 | carcinoid, lung | .j | 6651 to 7133 | 1 to 483 | Submitted on the opposite strand | 483/483 (100 %) | 2 diff (99.6 %id) | ||
BE327735 | carcinoid, lung | .j | 4104 to 4558 | 455 to 1 | 455/455 (100 %) | 2 diff (99.6 %id) | |||
BE464392 | Kidney | .j | 862 to 1197 | 336 to 1 | 336/336 (100 %) | 0 diff (100 %id) | |||
BF475690 | Prostate | .j | 1190 to 1579 | 1 to 390 | Submitted on the opposite strand | 390/390 (100 %) | 1 diff (99.8 %id) | ||
BF432111 | pooled | .j | 1190 to 1699 | 1 to 510 | Submitted on the opposite strand | 510/510 (100 %) | 0 diff (100 %id) | ||
BE671528 | carcinoid, lung | .j | 4141 to 4562 | 422 to 1 | 422/422 (100 %) | 1 diff (99.8 %id) | |||
BF591036 | colon, colon tumor, RER+ | .j | 769 to 1196 | 428 to 1 | 428/428 (100 %) | 6 diff (98.6 %id) | |||
BF114685 | pooled | .j | 1238 to 1756 | 1 to 519 | Submitted on the opposite strand | 519/519 (100 %) | 4 diff (99.3 %id) | ||
BG055039 | brain, glioblastoma (pooled) | .a | 1161 to 1890 | 723 to 1 | 723/723 (100 %) | 21 diff (97.1 %id) | |||
BF111702 | pooled | .j | 1190 to 1379 | 1 to 190 | Submitted on the opposite strand | 190/190 (100 %) | 0 diff (100 %id) | ||
BF112168 | pooled | .j | 673 to 1197 | 526 to 1 | 526/526 (100 %) | 2 diff (99.7 %id) | |||
BF110139 | carcinoid, lung | .j | 4252 to 4562 | 311 to 1 | 311/326 (95 %) | 7 diff (97.9 %id) | |||
BF434421 | fibrotheoma, ovary | .j | 6193 to 6715 | 1 to 523 | Submitted on the opposite strand | 523/523 (100 %) | 0 diff (100 %id) | ||
BF433462 | carcinoid, lung | .j | 6610 to 6886 | 1 to 277 | Submitted on the opposite strand | 277/277 (100 %) | 3 diff (99.0 %id) | ||
BE798975 | lung, small cell carcinoma | .a | 425 to 1275 | 35 to 873 | 839/941 (89 %) | 22 diff (97.7 %id) | |||
BE792646 | lung, small cell carcinoma | .i | 188 to 563 | 98 to 473 | 376/473 (79 %) | 0 diff (100 %id) | |||
BF942106 | medullary carcinoma, thyroid | .a | 1392 to 1850 | 1 to 459 | Submitted on the opposite strand | 459/459 (100 %) | 0 diff (100 %id) | ||
BF942273 | medullary carcinoma, thyroid | .a | 1392 to 1861 | 1 to 467 | Submitted on the opposite strand | 467/470 (99 %) | 4 diff (99.2 %id) | ||
BF303864 | muscle, rhabdomyosarcoma | .a | 509 to 1259 | 1 to 745 | 745/745 (100 %) | 11 diff (98.6 %id) | |||
BG055966 | anaplastic oligodendroglioma, brain | .a | 1476 to 1895 | 421 to 1 | 421/424 (99 %) | 1 diff (99.8 %id) | |||
BG055967 | anaplastic oligodendroglioma, brain | .a | 1540 to 1854 | 316 to 1 | 316/364 (86 %) | 17 diff (95.4 %id) | |||
BF663645 | B-cells, primary B-cells from tonsils (cell line) | .j | 259 to 892 | 1 to 632 | 632/886 (71 %) | 14 diff (98.5 %id) | |||
BG107571 | Bone, osteosarcoma, cell line | .j | 4105 to 4827 | 26 to 737 | 712/737 (96 %) | 0 diff (100 %id) | |||
BG109333 | Bone, osteosarcoma, cell line | .j | 2583 to 3357 | 1 to 769 | 769/942 (81 %) | 20 diff (97.9 %id) | |||
BF981594 | duodenal adenocarcinoma, cell line, small intestine | .j | 5024 to 5568 | 1 to 568 | 568/1274 (44 %) | 65 diff (94.9 %id) | |||
BC015343 | Breast, mammary adenocarcinoma. | .j | 4547 to 5275 | 17 to 745 | available from MGC, AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 729/729 (100 %) | 0 diff (100 %id) | |
BG032539 | breast, mammary adenocarcinoma, cell line | .j | 4547 to 5185 | 28 to 668 | available from MGC, | 641/745 (86 %) | 4 diff (99.5 %id) | ||
BG116542 | duodenal adenocarcinoma, cell line, small intestine | .j | 6699 to 7182 | 1 to 484 | AAA | 484/484 (100 %) | 3 diff (99.4 %id) | ||
BG286483 | bladder, transitional cell papilloma, cell line | .j | 6054 to 6174 | 466 to 592 | 519/1130 (45 %) | 25 diff (97.8 %id) | |||
BG341359 | B-cells, primary B-cells from tonsils (cell line) | .n | 1 to 782 | 1 to 768 | T68N K69Q K70E T71D S72V ... | tiling clone, AAA | 768/880 (87 %) | 27 diff (97.0 %id) | |
BG527236 | lung, mucoepidermoid carcinoma | .i | 304 to 962 | 1 to 663 | tiling clone, | 663/812 (81 %) | 11 diff (98.7 %id) | ||
BG576884 | breast, mammary adenocarcinoma, cell line | .j | 4156 to 4559 | 11 to 414 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 404/414 (97 %) | 0 diff (100 %id) | |
BG700238 | brain, hippocampus | .e | 56 to 778 | 1 to 724 | 724/724 (100 %) | 11 diff (98.5 %id) | |||
BG913767 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 1356 to 2015 | 2 to 671 | tiling clone, | 670/671 (99 %) | 11 diff (98.4 %id) | ||
BI224317 | cervical carcinoma cell line, cervix | .j | 5097 to 5808 | 1 to 719 | 719/811 (88 %) | 38 diff (95.4 %id) | |||
BI256833 | cervical carcinoma cell line, cervix | .j | 6591 to 7160 | 1 to 580 | 580/884 (65 %) | 35 diff (96.1 %id) | |||
BI546853 | brain, hippocampus | .e | 56 to 827 | 1 to 780 | 780/910 (85 %) | 21 diff (97.7 %id) | |||
BI544621 | brain, hippocampus | .e | 55 to 890 | 1 to 842 | 842/873 (96 %) | 26 diff (97.1 %id) | |||
BI858381 | breast, mammary adenocarcinoma, cell line | .j | 4350 to 4951 | 1 to 609 | 609/886 (68 %) | 16 diff (98.2 %id) | |||
BM801397 | duodenal adenocarcinoma, cell line, small intestine | .j | 3705 to 4238 | 1 to 536 | 536/974 (55 %) | 6 diff (99.4 %id) | |||
BM556801 | duodenal adenocarcinoma, cell line, small intestine | .j | 5596 to 6457 | 1 to 860 | 860/1033 (83 %) | 22 diff (97.9 %id) | |||
BQ267300 | insulinoma, Pancreas | .f | 1 to 431 | 1 to 431 | tiling clone, | 431/431 (100 %) | 5 diff (98.9 %id) | ||
BQ272543 | insulinoma, Pancreas | .a | 1426 to 1905 | 480 to 1 | tiling clone, | 480/480 (100 %) | 0 diff (100 %id) | ||
CK825300 | insulinoma, Pancreas | .a | 1311 to 1853 | 543 to 1 | 543/543 (100 %) | 4 diff (99.3 %id) | |||
CK825301 | insulinoma, Pancreas | .f | 1 to 407 | 1 to 408 | 408/476 (85 %) | 12 diff (97.5 %id) | |||
BQ017813 | Chondrosarcoma, Left Pubic Bone | .j | 4563 to 5278 | 731 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 716/716 (100 %) | 2 diff (99.8 %id) | |
BQ070945 | brain, neuroblastoma, cell line | .a | 531 to 1352 | 1 to 828 | tiling clone, | 828/1022 (81 %) | 9 diff (99.2 %id) | ||
BQ548669 | insulinoma, Pancreas | .f | 1220 to 1695 | 476 to 1 | tiling clone, | 476/476 (100 %) | 0 diff (100 %id) | ||
BQ548827 | insulinoma, Pancreas | .f | 156 to 734 | 1 to 579 | tiling clone, | 579/579 (100 %) | 3 diff (99.5 %id) | ||
CA771221 | Pancreas, Purified pancreatic islet | .a | 1445 to 1890 | 446 to 1 | 446/446 (100 %) | 0 diff (100 %id) | |||
CA771529 | Pancreas, Purified pancreatic islet | .a | 98 to 278 | 1 to 181 | 181/181 (100 %) | 0 diff (100 %id) | |||
BQ961069 | sciatic nerve | .h | 1353 to 2197 | 1 to 852 | tiling clone, | 852/931 (91 %) | 15 diff (98.4 %id) | ||
BU509171 | leiomyosarcoma, uterus | .j | 2921 to 3670 | 36 to 790 | 755/888 (85 %) | 18 diff (98.0 %id) | |||
CD557002 | brain, Pituitary | .a | 1393 to 1890 | 1 to 497 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 497/497 (100 %) | 5 diff (99.0 %id) | |
CD519529 | White Matter | .a | 1385 to 1890 | 1 to 506 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 506/506 (100 %) | 9 diff (98.3 %id) | |
TI_44167278 | .e | 62 to 827 | 87 to 860 | 774/990 (78 %) | 14 diff (98.6 %id) | ||||
TI_44000791 | .e | 61 to 890 | 92 to 928 | 837/959 (87 %) | 20 diff (98.0 %id) | ||||
TI_57187011 | .j | 4350 to 4951 | 53 to 661 | 609/886 (68 %) | 16 diff (98.2 %id) | ||||
DA647282 | mammary gland | .d | 1 to 809 | 2 to 807 | tiling clone, capped | 806/821 (98 %) | 7 diff (99.2 %id) | ||
DB362149 | mammary gland | .d | 1575 to 2082 | 508 to 1 | tiling clone, | 508/562 (90 %) | 5 diff (99.2 %id) | ||
NM_016524.2 | .a | 104 to 2015 | 1 to 1912 | RefSeq, | 1912/1912 (100 %) | 0 diff (100 %id) | |||
NM_001034841.3 | .c-u | 1 to 7694 | 2 to 7695 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) | 7695/7695 (100 %) | 0 diff (100 %id) | |
AV751842 | Pituitary | .q-u | 1290 to 1913 | 1 to 625 | tiling clone, | 625/717 (87 %) | 11 diff (98.5 %id) | ||
BP309393 | brain | .k | 1 to 580 | 1 to 582 | E99G F182X G183W L185F K188P ... | tiling clone, | 582/582 (100 %) | 3 diff (99.5 %id) | |
BP312114 | brain | .e | 1 to 575 | 2 to 579 | 579/582 (99 %) | 7 diff (98.8 %id) | |||
NR_028028.1 | .j | 1 to 7178 | 2 to 7179 | RefSeq, tiling clone, AAA | 7179/7179 (100 %) | 0 diff (100 %id) | |||
DA717408 | .j | 1 to 558 | 2 to 563 | capped | 562/562 (100 %) | 5 diff (99.2 %id) | |||
DB324187 | .j | 1491 to 2007 | 517 to 1 | 517/517 (100 %) | 0 diff (100 %id) | ||||
CD721916 | eye, lacrimal gland | .j | 3550 to 4189 | 1 to 641 | 641/641 (100 %) | 1 diff (99.9 %id) | |||
BM799306 | Ascites, stomach | .j | 3195 to 3731 | 1 to 537 | 537/537 (100 %) | 0 diff (100 %id) | |||
BM792354 | Ascites, stomach | .j | 1101 to 1388 | 1 to 289 | 289/291 (99 %) | 22 diff (92.5 %id) | |||
TI_1948145917 | .f | 238 to 921 | 145 to 841 | tiling clone, | 697/1399 (49 %) | 23 diff (98.4 %id) | |||
TI_1948145920 | .a | 1060 to 1858 | 935 to 137 | 799/1425 (56 %) | 35 diff (97.6 %id) | ||||
TI_1948146173 | .a | 1383 to 1858 | 611 to 131 | 481/1496 (32 %) | 23 diff (98.5 %id) | ||||
TI_1948146226 | .a | 429 to 1310 | 117 to 1007 | 891/1250 (71 %) | 20 diff (98.4 %id) | ||||
TI_1948146227 | .a | 435 to 904 | 117 to 588 | 472/1337 (35 %) | 18 diff (98.7 %id) | ||||
TI_1948146228 | .a | 1383 to 1858 | 601 to 126 | 476/1348 (35 %) | 2 diff (99.9 %id) | ||||
TI_1948146229 | .a | 935 to 1858 | 1051 to 129 | 923/1358 (67 %) | 26 diff (98.1 %id) | ||||
TI_1948146867 | .a | 435 to 991 | 126 to 687 | 562/1427 (39 %) | 11 diff (99.3 %id) | ||||
TI_1948146870 | .a | 1080 to 1858 | 918 to 132 | 787/1492 (52 %) | 24 diff (98.4 %id) | ||||
DA948521 | Spleen | .c-u | 555 to 1116 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DB333655 | Spleen | .c-u | 2060 to 2518 | 464 to 6 | 459/465 (98 %) | 0 diff (100 %id) | |||
BP350467 | brain | .i | 72 to 660 | 1 to 588 | 588/588 (100 %) | 1 diff (99.9 %id) | |||
DN990237 | brain, whole brain | .e | -10 to 531 | 1 to 542 | 542/542 (100 %) | 5 diff (99.1 %id) | |||
BM194041 | leukopheresis | .j | 2797 to 3292 | 496 to 1 | 496/496 (100 %) | 2 diff (99.6 %id) | |||
BE247159 | leukopheresis | .j | 283 to 687 | 1 to 405 | 405/405 (100 %) | 0 diff (100 %id) | |||
BE247184 | leukopheresis | .j | 2946 to 3292 | 347 to 1 | 347/349 (99 %) | 0 diff (100 %id) | |||
TI_149275040 | .j | 3986 to 4559 | 660 to 85 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 576/996 (57 %) | 1 diff (99.9 %id) | ||
TI_149296919 | .q-u | 1495 to 2260 | 848 to 87 | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 762/908 (83 %) | 7 diff (99.3 %id) | ||
TI_149302217 | .q-u | 1298 to 2264 | 1016 to 77 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 940/986 (95 %) | 34 diff (96.6 %id) | ||
TI_153987637 | .j | 4710 to 5253 | 78 to 621 | Submitted on the opposite strand | 544/621 (87 %) | 0 diff (100 %id) | |||
TI_154021143 | .j | 6502 to 7178 | 765 to 89 | AAA | 677/679 (99 %) | 25 diff (96.4 %id) | |||
TI_154114048 | .b | 1262 to 1720 | 558 to 100 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 459/460 (99 %) | 1 diff (99.8 %id) | ||
TI_154151822 | .j | 3355 to 4030 | 749 to 80 | Submitted on the opposite strand | 670/671 (99 %) | 27 diff (96.0 %id) | |||
TI_154154276 | .j | 3395 to 4033 | 734 to 96 | Submitted on the opposite strand | 639/656 (97 %) | 0 diff (100 %id) | |||
TI_157598347 | .j | 1190 to 1929 | 56 to 783 | Submitted on the opposite strand | 728/1022 (71 %) | 18 diff (98.3 %id) | |||
TI_157602330 | .j | 1190 to 1766 | 76 to 656 | Submitted on the opposite strand | 581/1051 (55 %) | 0 diff (100 %id) | |||
TI_157602796 | .j | 1190 to 1637 | 77 to 522 | Submitted on the opposite strand | 446/925 (48 %) | 3 diff (99.7 %id) | |||
TI_157603464 | .j | 1190 to 1920 | 85 to 807 | Submitted on the opposite strand | 723/963 (75 %) | 16 diff (98.4 %id) | |||
TI_157604181 | .j | 1190 to 1706 | 85 to 601 | Submitted on the opposite strand | 517/1122 (46 %) | 12 diff (99.0 %id) | |||
TI_157607442 | .j | 1190 to 1755 | 77 to 647 | Submitted on the opposite strand | 571/1157 (49 %) | 12 diff (99.0 %id) | |||
TI_157612401 | .j | 667 to 1197 | 605 to 70 | 536/616 (87 %) | 0 diff (100 %id) | ||||
TI_159701051 | .j | 178 to 1199 | 1039 to 51 | 989/1132 (87 %) | 0 diff (100 %id) | ||||
BU676504 | lung, Primary Lung Epithelial Cells | .j | 3986 to 4559 | 594 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 576/711 (81 %) | 1 diff (99.9 %id) | |
BM982070 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .q-u | 1583 to 2260 | 696 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 678/678 (100 %) | 0 diff (100 %id) | |
BM980456 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .q-u | 1579 to 2264 | 700 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 682/682 (100 %) | 4 diff (99.5 %id) | |
BM714007 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1259 to 1840 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
CA428849 | Bone, Subchondral Bone | .j | 6178 to 6823 | 664 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 646/646 (100 %) | 2 diff (99.7 %id) | |
CA427626 | Bone, Subchondral Bone | .j | 6494 to 7178 | 703 to 19 | AAA | 685/685 (100 %) | 0 diff (100 %id) | ||
CA448905 | Chondrosarcoma, Left Pelvis | .b | 1282 to 1720 | 457 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 439/439 (100 %) | 1 diff (99.8 %id) | |
BQ773852 | Chondrosarcoma Grade II, Left Pelvis | .j | 1354 to 2025 | 671 to 1 | 671/671 (100 %) | 2 diff (99.8 %id) | |||
CA424519 | cell lines, Chondrosarcoma | .j | 4539 to 5278 | 753 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 738/738 (100 %) | 2 diff (99.8 %id) | |
BQ773990 | Bone, Human Chondrosarcoma Cell Line | .j | 3320 to 4016 | 715 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 697/697 (100 %) | 8 diff (98.9 %id) | |
TI_151753481 | .a | 1259 to 1890 | 707 to 71 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 637/1154 (55 %) | 10 diff (99.2 %id) | ||
AK226136 | brain | .i | 304 to 962 | 1 to 663 | tiling clone, AAA | Suspected internal deletion, this clone was ignored | 663/812 (81 %) | 11 diff (98.7 %id) | |
BE091601 | breast | .i | 304 to 962 | 1 to 663 | tiling clone, | Suspected internal deletion, this clone was ignored | 663/812 (81 %) | 11 diff (98.7 %id) | |
BE814541 | breast_normal | .j | 4156 to 4559 | 11 to 414 | This clone was ignored | 404/414 (97 %) | 0 diff (100 %id) | ||
DC318799 | brain | .j | 4156 to 4559 | 11 to 414 | This clone was ignored | 404/414 (97 %) | 0 diff (100 %id) | ||
DC425849 | brain | .e | 56 to 778 | 1 to 724 | This clone was ignored | 724/724 (100 %) | 11 diff (98.5 %id) | ||
DC338670 | subthalamic nucleus | .e | 56 to 778 | 1 to 724 | Suspected internal deletion, this clone was ignored | 724/724 (100 %) | 11 diff (98.5 %id) | ||
F04792 | brain, total brain | .a | 1356 to 2015 | 2 to 671 | tiling clone, | This clone was ignored | 670/671 (99 %) | 11 diff (98.4 %id) | |
F08582 | brain, total brain | .a | 1356 to 2015 | 2 to 671 | tiling clone, | This clone was ignored | 670/671 (99 %) | 11 diff (98.4 %id) | |
BP208819 | cerebellum | .j | 5097 to 5808 | 1 to 719 | Suspected internal deletion, this clone was ignored | 719/811 (88 %) | 38 diff (95.4 %id) | ||
BX351188 | Neuroblastoma Cot 25-normalized | .j | 5097 to 5808 | 1 to 719 | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored | 719/811 (88 %) | 38 diff (95.4 %id) | ||
BX394959 | Neuroblastoma Cot 25-normalized | .j | 6591 to 7160 | 1 to 580 | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored | 580/884 (65 %) | 35 diff (96.1 %id) | ||
DA437998 | tongue, tumor tissue | .j | 6591 to 7160 | 1 to 580 | capped | This clone was ignored | 580/884 (65 %) | 35 diff (96.1 %id) | |
DB313490 | tongue, tumor tissue | .e | 56 to 827 | 1 to 780 | This clone was ignored | 780/910 (85 %) | 21 diff (97.7 %id) | ||
EL946280 | eyeball | .e | 56 to 827 | 1 to 780 | Submitted on the opposite strand | 780/910 (85 %) | 21 diff (97.7 %id) | ||
DB538418 | hippocampus | .e | 55 to 890 | 1 to 842 | Submitted on the opposite strand | 842/873 (96 %) | 26 diff (97.1 %id) | ||
DB539805 | hippocampus | .e | 55 to 890 | 1 to 842 | Submitted on the opposite strand | 842/873 (96 %) | 26 diff (97.1 %id) | ||
DB544528 | hippocampus | .j | 4350 to 4951 | 1 to 609 | Submitted on the opposite strand | 609/886 (68 %) | 16 diff (98.2 %id) | ||
DB547080 | hippocampus | .j | 4350 to 4951 | 1 to 609 | Submitted on the opposite strand | 609/886 (68 %) | 16 diff (98.2 %id) | ||
R53046 | whole brain | .j | 3705 to 4238 | 1 to 536 | This clone was ignored | 536/974 (55 %) | 6 diff (99.4 %id) | ||
AA865596 | pooled germ cell tumors | .j | 3705 to 4238 | 1 to 536 | This clone was ignored | 536/974 (55 %) | 6 diff (99.4 %id) | ||
AI198391 | anaplastic oligodendroglioma, brain | .j | 5596 to 6457 | 1 to 860 | This clone was ignored | 860/1033 (83 %) | 22 diff (97.9 %id) | ||
AI582818 | anaplastic oligodendroglioma, brain | .j | 5596 to 6457 | 1 to 860 | This clone was ignored | 860/1033 (83 %) | 22 diff (97.9 %id) | ||
AV750922 | Pituitary | .f | 1 to 431 | 1 to 431 | tiling clone, | Submitted on the opposite strand | 431/431 (100 %) | 5 diff (98.9 %id) | |
DA860272 | placenta | .f | 1 to 431 | 1 to 431 | tiling clone, capped | This clone was ignored | 431/431 (100 %) | 5 diff (98.9 %id) | |
DB329018 | placenta | .a | 1426 to 1905 | 480 to 1 | tiling clone, | This clone was ignored | 480/480 (100 %) | 0 diff (100 %id) | |
TI_149291131 | .a | 1426 to 1905 | 480 to 1 | tiling clone, AAA | This clone was ignored | 480/480 (100 %) | 0 diff (100 %id) | ||
BM973871 | lung | .a | 1311 to 1853 | 543 to 1 | AAA | This clone was ignored | 543/543 (100 %) | 4 diff (99.3 %id) | |
BM680503 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1311 to 1853 | 543 to 1 | Suspected internal deletion, this clone was ignored | 543/543 (100 %) | 4 diff (99.3 %id) | ||
BM718052 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .f | 1 to 407 | 1 to 408 | Suspected internal deletion, this clone was ignored | 408/476 (85 %) | 12 diff (97.5 %id) | ||
CA439023 | lung, Lung Focal Fibrosis | .f | 1 to 407 | 1 to 408 | Submitted on the opposite strand, submitted on the opposite strand | 408/476 (85 %) | 12 diff (97.5 %id) | ||
BQ017813 | Chondrosarcoma, Left Pubic Bone | .j | 4563 to 5278 | 731 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 716/716 (100 %) | 2 diff (99.8 %id) | |
BQ017813 | Chondrosarcoma, Left Pubic Bone | .j | 4563 to 5278 | 731 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 716/716 (100 %) | 2 diff (99.8 %id) | |
BQ070945 | brain, neuroblastoma, cell line | .a | 531 to 1352 | 1 to 828 | tiling clone, | 828/1022 (81 %) | 9 diff (99.2 %id) | ||
BQ070945 | brain, neuroblastoma, cell line | .a | 531 to 1352 | 1 to 828 | tiling clone, | 828/1022 (81 %) | 9 diff (99.2 %id) | ||
BQ548669 | insulinoma, Pancreas | .f | 1220 to 1695 | 476 to 1 | tiling clone, | 476/476 (100 %) | 0 diff (100 %id) | ||
BQ548669 | insulinoma, Pancreas | .f | 1220 to 1695 | 476 to 1 | tiling clone, | 476/476 (100 %) | 0 diff (100 %id) | ||
BQ548827 | insulinoma, Pancreas | .f | 156 to 734 | 1 to 579 | tiling clone, | 579/579 (100 %) | 3 diff (99.5 %id) | ||
BQ548827 | insulinoma, Pancreas | .f | 156 to 734 | 1 to 579 | tiling clone, | 579/579 (100 %) | 3 diff (99.5 %id) | ||
CA771221 | Pancreas, Purified pancreatic islet | .a | 1445 to 1890 | 446 to 1 | 446/446 (100 %) | 0 diff (100 %id) | |||
CA771221 | Pancreas, Purified pancreatic islet | .a | 1445 to 1890 | 446 to 1 | 446/446 (100 %) | 0 diff (100 %id) | |||
CA771529 | Pancreas, Purified pancreatic islet | .a | 98 to 278 | 1 to 181 | 181/181 (100 %) | 0 diff (100 %id) | |||
CA771529 | Pancreas, Purified pancreatic islet | .a | 98 to 278 | 1 to 181 | 181/181 (100 %) | 0 diff (100 %id) | |||
BQ961069 | sciatic nerve | .h | 1353 to 2197 | 1 to 852 | tiling clone, | 852/931 (91 %) | 15 diff (98.4 %id) | ||
BU509171 | leiomyosarcoma, uterus | .j | 2921 to 3670 | 36 to 790 | 755/888 (85 %) | 18 diff (98.0 %id) | |||
BU509171 | leiomyosarcoma, uterus | .j | 2921 to 3670 | 36 to 790 | 755/888 (85 %) | 18 diff (98.0 %id) | |||
CD557002 | brain, Pituitary | .a | 1393 to 1890 | 1 to 497 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 497/497 (100 %) | 5 diff (99.0 %id) | |
CD557002 | brain, Pituitary | .a | 1393 to 1890 | 1 to 497 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 497/497 (100 %) | 5 diff (99.0 %id) | |
CD519529 | White Matter | .a | 1385 to 1890 | 1 to 506 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 506/506 (100 %) | 9 diff (98.3 %id) | |
TI_44167278 | .e | 62 to 827 | 87 to 860 | 774/990 (78 %) | 14 diff (98.6 %id) | ||||
TI_44000791 | .e | 61 to 890 | 92 to 928 | 837/959 (87 %) | 20 diff (98.0 %id) | ||||
TI_57187011 | .j | 4350 to 4951 | 53 to 661 | 609/886 (68 %) | 16 diff (98.2 %id) | ||||
DA647282 | mammary gland | .d | 1 to 809 | 2 to 807 | tiling clone, capped | 806/821 (98 %) | 7 diff (99.2 %id) | ||
DB362149 | mammary gland | .d | 1575 to 2082 | 508 to 1 | tiling clone, | 508/562 (90 %) | 5 diff (99.2 %id) | ||
NM_016524.2 | .a | 104 to 2015 | 1 to 1912 | RefSeq, | 1912/1912 (100 %) | 0 diff (100 %id) | |||
NM_001034841.3 | .c-u | 1 to 7694 | 2 to 7695 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) | 7695/7695 (100 %) | 0 diff (100 %id) | |
AV751842 | Pituitary | .q-u | 1290 to 1913 | 1 to 625 | tiling clone, | 625/717 (87 %) | 11 diff (98.5 %id) | ||
BP309393 | brain | .k | 1 to 580 | 1 to 582 | E99G F182X G183W L185F K188P ... | tiling clone, | 582/582 (100 %) | 3 diff (99.5 %id) | |
BP312114 | brain | .e | 1 to 575 | 2 to 579 | 579/582 (99 %) | 7 diff (98.8 %id) | |||
NR_028028.1 | .j | 1 to 7178 | 2 to 7179 | RefSeq, tiling clone, AAA | 7179/7179 (100 %) | 0 diff (100 %id) | |||
DA717408 | .j | 1 to 558 | 2 to 563 | capped | 562/562 (100 %) | 5 diff (99.2 %id) | |||
DB324187 | .j | 1491 to 2007 | 517 to 1 | 517/517 (100 %) | 0 diff (100 %id) | ||||
CD721916 | eye, lacrimal gland | .j | 3550 to 4189 | 1 to 641 | 641/641 (100 %) | 1 diff (99.9 %id) | |||
CD721916 | eye, lacrimal gland | .j | 3550 to 4189 | 1 to 641 | 641/641 (100 %) | 1 diff (99.9 %id) | |||
BM799306 | Ascites, stomach | .j | 3195 to 3731 | 1 to 537 | 537/537 (100 %) | 0 diff (100 %id) | |||
BM799306 | Ascites, stomach | .j | 3195 to 3731 | 1 to 537 | 537/537 (100 %) | 0 diff (100 %id) | |||
BM792354 | Ascites, stomach | .j | 1101 to 1388 | 1 to 289 | 289/291 (99 %) | 22 diff (92.5 %id) | |||
BM792354 | Ascites, stomach | .j | 1101 to 1388 | 1 to 289 | 289/291 (99 %) | 22 diff (92.5 %id) | |||
TI_1948145917 | .f | 238 to 921 | 145 to 841 | tiling clone, | 697/1399 (49 %) | 23 diff (98.4 %id) | |||
TI_1948145920 | .a | 1060 to 1858 | 935 to 137 | 799/1425 (56 %) | 35 diff (97.6 %id) | ||||
TI_1948146173 | .a | 1383 to 1858 | 611 to 131 | 481/1496 (32 %) | 23 diff (98.5 %id) | ||||
TI_1948146226 | .a | 429 to 1310 | 117 to 1007 | 891/1250 (71 %) | 20 diff (98.4 %id) | ||||
TI_1948146227 | .a | 435 to 904 | 117 to 588 | 472/1337 (35 %) | 18 diff (98.7 %id) | ||||
TI_1948146228 | .a | 1383 to 1858 | 601 to 126 | 476/1348 (35 %) | 2 diff (99.9 %id) | ||||
TI_1948146229 | .a | 935 to 1858 | 1051 to 129 | 923/1358 (67 %) | 26 diff (98.1 %id) | ||||
TI_1948146867 | .a | 435 to 991 | 126 to 687 | 562/1427 (39 %) | 11 diff (99.3 %id) | ||||
TI_1948146870 | .a | 1080 to 1858 | 918 to 132 | 787/1492 (52 %) | 24 diff (98.4 %id) | ||||
DA948521 | Spleen | .c-u | 555 to 1116 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DB333655 | Spleen | .c-u | 2060 to 2518 | 464 to 6 | 459/465 (98 %) | 0 diff (100 %id) | |||
BP350467 | brain | .i | 72 to 660 | 1 to 588 | 588/588 (100 %) | 1 diff (99.9 %id) | |||
DN990237 | brain, whole brain | .e | -10 to 531 | 1 to 542 | 542/542 (100 %) | 5 diff (99.1 %id) | |||
DN990237 | brain, whole brain | .e | -10 to 531 | 1 to 542 | 542/542 (100 %) | 5 diff (99.1 %id) | |||
BM194041 | leukopheresis | .j | 2797 to 3292 | 496 to 1 | 496/496 (100 %) | 2 diff (99.6 %id) | |||
BE247159 | leukopheresis | .j | 283 to 687 | 1 to 405 | 405/405 (100 %) | 0 diff (100 %id) | |||
BE247184 | leukopheresis | .j | 2946 to 3292 | 347 to 1 | 347/349 (99 %) | 0 diff (100 %id) | |||
TI_149275040 | .j | 3986 to 4559 | 660 to 85 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 576/996 (57 %) | 1 diff (99.9 %id) | ||
TI_149296919 | .q-u | 1495 to 2260 | 848 to 87 | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 762/908 (83 %) | 7 diff (99.3 %id) | ||
TI_149302217 | .q-u | 1298 to 2264 | 1016 to 77 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 940/986 (95 %) | 34 diff (96.6 %id) | ||
TI_153987637 | .j | 4710 to 5253 | 78 to 621 | Submitted on the opposite strand | 544/621 (87 %) | 0 diff (100 %id) | |||
TI_154021143 | .j | 6502 to 7178 | 765 to 89 | AAA | 677/679 (99 %) | 25 diff (96.4 %id) | |||
TI_154114048 | .b | 1262 to 1720 | 558 to 100 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 459/460 (99 %) | 1 diff (99.8 %id) | ||
TI_154151822 | .j | 3355 to 4030 | 749 to 80 | Submitted on the opposite strand | 670/671 (99 %) | 27 diff (96.0 %id) | |||
TI_154154276 | .j | 3395 to 4033 | 734 to 96 | Submitted on the opposite strand | 639/656 (97 %) | 0 diff (100 %id) | |||
TI_157598347 | .j | 1190 to 1929 | 56 to 783 | Submitted on the opposite strand | 728/1022 (71 %) | 18 diff (98.3 %id) | |||
TI_157602330 | .j | 1190 to 1766 | 76 to 656 | Submitted on the opposite strand | 581/1051 (55 %) | 0 diff (100 %id) | |||
TI_157602796 | .j | 1190 to 1637 | 77 to 522 | Submitted on the opposite strand | 446/925 (48 %) | 3 diff (99.7 %id) | |||
TI_157603464 | .j | 1190 to 1920 | 85 to 807 | Submitted on the opposite strand | 723/963 (75 %) | 16 diff (98.4 %id) | |||
TI_157604181 | .j | 1190 to 1706 | 85 to 601 | Submitted on the opposite strand | 517/1122 (46 %) | 12 diff (99.0 %id) | |||
TI_157607442 | .j | 1190 to 1755 | 77 to 647 | Submitted on the opposite strand | 571/1157 (49 %) | 12 diff (99.0 %id) | |||
TI_157612401 | .j | 667 to 1197 | 605 to 70 | 536/616 (87 %) | 0 diff (100 %id) | ||||
TI_159701051 | .j | 178 to 1199 | 1039 to 51 | 989/1132 (87 %) | 0 diff (100 %id) | ||||
BU676504 | lung, Primary Lung Epithelial Cells | .j | 3986 to 4559 | 594 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 576/711 (81 %) | 1 diff (99.9 %id) | |
BU676504 | lung, Primary Lung Epithelial Cells | .j | 3986 to 4559 | 594 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 576/711 (81 %) | 1 diff (99.9 %id) | |
BM982070 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .q-u | 1583 to 2260 | 696 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 678/678 (100 %) | 0 diff (100 %id) | |
BM982070 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .q-u | 1583 to 2260 | 696 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 678/678 (100 %) | 0 diff (100 %id) | |
BM980456 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .q-u | 1579 to 2264 | 700 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 682/682 (100 %) | 4 diff (99.5 %id) | |
BM980456 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .q-u | 1579 to 2264 | 700 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 682/682 (100 %) | 4 diff (99.5 %id) | |
BM714007 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1259 to 1840 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BM714007 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1259 to 1840 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
CA428849 | Bone, Subchondral Bone | .j | 6178 to 6823 | 664 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 646/646 (100 %) | 2 diff (99.7 %id) | |
CA428849 | Bone, Subchondral Bone | .j | 6178 to 6823 | 664 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 646/646 (100 %) | 2 diff (99.7 %id) | |
CA427626 | Bone, Subchondral Bone | .j | 6494 to 7178 | 703 to 19 | AAA | 685/685 (100 %) | 0 diff (100 %id) | ||
CA427626 | Bone, Subchondral Bone | .j | 6494 to 7178 | 703 to 19 | AAA | 685/685 (100 %) | 0 diff (100 %id) | ||
CA448905 | Chondrosarcoma, Left Pelvis | .b | 1282 to 1720 | 457 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 439/439 (100 %) | 1 diff (99.8 %id) | |
CA448905 | Chondrosarcoma, Left Pelvis | .b | 1282 to 1720 | 457 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 439/439 (100 %) | 1 diff (99.8 %id) | |
BQ773852 | Chondrosarcoma Grade II, Left Pelvis | .j | 1354 to 2025 | 671 to 1 | 671/671 (100 %) | 2 diff (99.8 %id) | |||
BQ773852 | Chondrosarcoma Grade II, Left Pelvis | .j | 1354 to 2025 | 671 to 1 | 671/671 (100 %) | 2 diff (99.8 %id) | |||
CA424519 | cell lines, Chondrosarcoma | .j | 4539 to 5278 | 753 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 738/738 (100 %) | 2 diff (99.8 %id) | |
CA424519 | cell lines, Chondrosarcoma | .j | 4539 to 5278 | 753 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 738/738 (100 %) | 2 diff (99.8 %id) | |
BQ773990 | Bone, Human Chondrosarcoma Cell Line | .j | 3320 to 4016 | 715 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 697/697 (100 %) | 8 diff (98.9 %id) | |
BQ773990 | Bone, Human Chondrosarcoma Cell Line | .j | 3320 to 4016 | 715 to 19 | AAA | Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) | 697/697 (100 %) | 8 diff (98.9 %id) | |
TI_151753481 | .a | 1259 to 1890 | 707 to 71 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 637/1154 (55 %) | 10 diff (99.2 %id) |